NOVEL Study

Start date:April 2019

End date:April 2021

Co-ordinated by:LumiraDx

Main trial site:Royal Infirmary Edinburgh

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.